« Back to Record
Citation APA

Reardon, D. D., Dresemann, G., Taillibert, S., Campone, M., van den Bent, M. M., Clement, P. M. J. P., Blomquist, E., Gordower, L., Schultz, H., Raizer, J., Hau, P., Easaw, J., Gil, M., Tonn, J. C. J., Gijtenbeek, A. M. M. A., Schlegel, U., Bergstrom, P., Green, S. S., Weir, A. B. A., & Nikolova, Z. (2009). Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British Journal of Cancer, 101(12), 1995-2004. doi:10.1038/sj.bjc.6605411


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/181315

Reardon, D. D., Dresemann, G., Taillibert, S., Campone, M., van den Bent, M. M., Clement, P. M. J. P., Blomquist, E., Gordower, L., Schultz, H., Raizer, J., Hau, P., Easaw, J., Gil, M., Tonn, J. C. J., Gijtenbeek, A. M. M. A., Schlegel, U., Bergstrom, P., Green, S. S., Weir, A. B. A., & Nikolova, Z. (2009). Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British Journal of Cancer, 101(12), 1995-2004. doi:10.1038/sj.bjc.6605411